Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

361. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction

Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Patatanian E, Fugate SE CRD summary This 2006 review concluded that dental extractions in anticoagulated patients could be performed with haemostatic mouthwashes to control local bleeding, without temporary discontinuation of oral anticoagulants. The limitations (...) of the review methods, and a lack of data on thromboembolism risk, mean that these conclusions may be overstated. Authors' objectives To evaluate the efficacy and safety of local-acting haemostatic agents to prevent bleeding in patients taking oral anticoagulants and undergoing dental extraction. Searching MEDLINE, IPA and EMBASE were searched in July 2006 for English-language publications. Search terms were reported. Bibliographies of relevant papers were manually searched. Study selection Eligible

DARE.2006

362. Review: self testing and self management increase the benefits and reduce the harms of anticoagulant therapy

Review: self testing and self management increase the benefits and reduce the harms of anticoagulant therapy Review: self testing and self management increase the benefits and reduce the harms of anticoagulant therapy | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: self testing and self management increase the benefits and reduce the harms of anticoagulant therapy Article Text Treatment Review: self testing and self management increase the benefits and reduce the harms of anticoagulant therapy

Evidence-Based Nursing (Requires free registration)2006

363. Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation

Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation Article Text Therapeutics Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation Statistics from

Evidence-Based Medicine (Requires free registration)2006

364. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Journals Library An error has occurred in processing the XML document An error occurred retrieving

NIHR HTA programme2006

365. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. 16765759 2006 06 12 2006 06 22 2016 11 24 1474-547X 367 9526 2006 Jun 10 Lancet (London, England) Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE (...) W): a randomised controlled trial. 1903-12 Oral anticoagulation therapy reduces risk of vascular events in patients with atrial fibrillation. However, long-term monitoring is necessary and many patients cannot achieve optimum anticoagulation. We assessed whether clopidogrel plus aspirin was non-inferior to oral anticoagulation therapy for prevention of vascular events. Patients were enrolled if they had atrial fibrillation plus one or more risk factor for stroke, and were randomly allocated

Lancet2006

366. D-dimer testing to determine the duration of anticoagulation therapy.

D-dimer testing to determine the duration of anticoagulation therapy. 17065639 2006 10 26 2006 11 01 2016 11 24 1533-4406 355 17 2006 Oct 26 The New England journal of medicine N. Engl. J. Med. D-dimer testing to determine the duration of anticoagulation therapy. 1780-9 The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation. We performed D (...) -dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average

NEJM2006

367. Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department

Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department BestBets: Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department Report By: Katherine Potier - Specialist Registrar in Emergency Medicine Search checked by Richard Parris - Locum Consultant Institution: Manchester Royal Infirmary Date Submitted: 17th September 2004 Date (...) Completed: 12th April 2005 Last Modified: 6th January 2005 Status: Green (complete) Three Part Question In a patient with [acute atrial fibrillation undergoing cardioversion in the emergency department] does [anticoagulation immediately before cardioversion] [reduce the incidence of thrombo-embolism]? Clinical Scenario A 58 year old man presents to the emergency department with a 24 hour history of new onset AF. You decide to cardiovert him in the department (chemically or electrically) and wonder

BestBETS2005

368. Anticoagulation post- cardioversion of acute atrial fibrillation in the emergency department

Anticoagulation post- cardioversion of acute atrial fibrillation in the emergency department BestBets: Anticoagulation post-cardioversion of acute atrial fibrillation in the emergency department Anticoagulation post-cardioversion of acute atrial fibrillation in the emergency department Report By: Katherine Potier - Specialist Registrar, Emergency Medicine Search checked by Richard Parris - Locum ED Consultant Institution: Emergency Department, Royal Bolton Hospital Date Submitted: 17th (...) September 2004 Date Completed: 12th April 2005 Last Modified: 6th January 2005 Status: Green (complete) Three Part Question In a [patient with acute atrial fibrillation who has cardioverted to sinus rhythm] does [anticoagulation post-cardioversion] [reduce the incidence of thromboembolic complications]? Clinical Scenario A 45 year old man who presented to your emergency department with new onset AF has been successfully chemically cardioverted. You wonder whether he needs anti-coagulating on discharge

BestBETS2005

369. Duration of anticoagulation following venous thromboebolism: a meta-analysis

Duration of anticoagulation following venous thromboebolism: a meta-analysis Duration of anticoagulation following venous thromboebolism: a meta-analysis Duration of anticoagulation following venous thromboebolism: a meta-analysis Ost D, Tepper J, Mihara H, Lander O, Heinzer R, Fein A CRD summary This review found that, compared with short-term anticoagulation therapy, long-term anticoagulation therapy can protect against recurrent venous thromboembolism. This was a well-conducted review (...) and the conclusions are reliable based on the evidence presented. However, it is possible that some relevant studies might not have been identified. Authors' objectives To quantify the risks and benefits of extending the duration of anticoagulation in patients with venous thromboembolism (VTE). Searching PubMed, EMBASE: Pharmacology and the Cochrane CENTRAL Register were searched from 1969 to 2004 for articles in the English language; the search terms were reported. Clinical trial websites and citations

DARE.2005

370. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews (...) of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, Baigent C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, Baigent C. Towards evidence-based guidelines for the prevention

Health Technology Assessment (HTA) Database.2005

371. Perioperative anticoagulation for patients with mechanical heart valves: a model comparing unfractionated and low-molecular-weight heparin

Perioperative anticoagulation for patients with mechanical heart valves: a model comparing unfractionated and low-molecular-weight heparin Perioperative anticoagulation for patients with mechanical heart valves: a model comparing unfractionated and low-molecular-weight heparin Perioperative anticoagulation for patients with mechanical heart valves: a model comparing unfractionated and low-molecular-weight heparin Garcia D A, Libby E N, Rich J S Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of intravenous (IV) unfractionated heparin (UFH) and low molecular weight heparins (LMWH) for short-term perioperative anticoagulation in patients with mechanical heart valves undergoing invasive procedures. Type

NHS Economic Evaluation Database.2005

372. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event

Oral anticoagulation strategies after a first idiopathic venous thromboembolic event Oral anticoagulation strategies after a first idiopathic venous thromboembolic event Oral anticoagulation strategies after a first idiopathic venous thromboembolic event Aujesky D, Smith K J, Roberts M S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined six strategies for the treatment of 40- to 80-year-old men and women after their first idiopathic venous thromboembolic event or pulmonary embolism (PE) and after a standard 3-month course of conventional-intensity anticoagulation therapy with warfarin. Strategy 1 was the discontinuation of anticoagulation (i.e. the 3-month strategy). Strategy 2 was conventional-intensity

NHS Economic Evaluation Database.2005

373. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care (...) study Menzin J, Boulanger L, Hauch O, Friedman M, Marple C B, Wygant G, Hurley J S, Pezzella S, Kaatz S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared the costs and outcomes from anticoagulation clinics in three

NHS Economic Evaluation Database.2005

375. Self management of oral anticoagulation: randomised trial.

Self management of oral anticoagulation: randomised trial. 16216821 2005 11 04 2005 11 15 2014 06 05 1756-1833 331 7524 2005 Nov 05 BMJ (Clinical research ed.) BMJ Self management of oral anticoagulation: randomised trial. 1057 To determine the clinical effectiveness of self management compared with routine care in patients on long term oral anticoagulants. Multicentre open randomised controlled trial. Midlands region of the UK. 617 patients aged over 18 and receiving warfarin randomised (...) %). Self managed patients with poor control before the study showed an improvement in control that was not seen in the routine care group. Nine patients (2.8/100 patient years) had serious adverse events in the self managed group, compared with seven (2.7/100 patient years) in the routine care arm (chi2(df = 1) = 0.02, P = 0.89). With appropriate training, self management is safe and reliable for a sizeable proportion of patients receiving oral anticoagulation treatment. It may improve the time spent

BMJ2005 Full Text: Link to full Text with Trip Pro

376. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. BACKGROUND: The risk for atrial fibrillation-associated stroke increases at low anticoagulation intensities. However, higher intensities increase hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires precise information on the risk for intracranial hemorrhage as a function of patient age and anticoagulation intensity. OBJECTIVE: To examine (...) the relationship of age, anticoagulation intensity, and risk for intracranial hemorrhage. DESIGN: Case-control study. SETTING: Academic medical center. PATIENTS: 170 case-patients who developed intracranial hemorrhage during warfarin therapy and 1020 matched controls who did not; both case-patients and controls were taking warfarin for atrial fibrillation. MEASUREMENTS: The authors performed multivariable conditional logistic regression to determine the odds of intracranial hemorrhage with regard to age

Annals of Internal Medicine2004

377. Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis.

Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis. BACKGROUND: Negative results on simplified compression ultrasonography cannot rule out symptomatic deep venous thrombosis (DVT) without further testing, such as repeated ultrasonography several days later. Repeated testing is costly and inconvenient, and patients are sometimes less likely to return for follow-up tests. OBJECTIVE: To determine the rate of venous (...) thromboembolism when anticoagulation is withheld in patients with symptoms of DVT of the leg after negative results on a single examination with comprehensive duplex ultrasonography. DESIGN: Prospective clinical cohort study. SETTING: Peripheral vascular laboratory of a tertiary care academic hospital. PATIENTS: 445 consecutive patients in whom a first episode of symptomatic DVT was suspected. INTERVENTION: The researchers examined the entire leg with comprehensive duplex ultrasonography, using compression

Annals of Internal Medicine2004

378. Resolution of left atrial thrombus after 6 months of anticoagulation in candidates for percutaneous transvenous mitral commissurotomy.

Resolution of left atrial thrombus after 6 months of anticoagulation in candidates for percutaneous transvenous mitral commissurotomy. BACKGROUND: Resolution of left atrial thrombus after long-term oral anticoagulation enhances safe percutaneous transvenous mitral commissurotomy (PTMC); however, the short-term benefit has not been defined. OBJECTIVES: To estimate the resolution rate of left atrial thrombus among PTMC candidates after 6 months of oral anticoagulation and to determine its main (...) thrombus size of 1.6 cm2 or less, a left atrial spontaneous echocardiographic contrast grade of 1 or less, and an international normalized ratio (INR) of at least 2.5. Patients with all of these predictors had a 94.4% chance of complete thrombus resolution (CI, 84.4% to 98.1%). CONCLUSIONS: After 6 months of oral anticoagulation, the left atrial thrombus disappeared in about a quarter of PTMC candidates so they could safely undergo PTMC. Less clinical severity, lower grading of the left atrial

Annals of Internal Medicine2004

379. Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction

Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction Gibbs W J, Fugate S E, Vesta K S CRD summary This review assessed the efficacy and safety of oral anticoagulation, with or without aspirin, for secondary prevention of myocardial infarction (...) . The authors concluded that oral anticoagulation was at least as effective as aspirin, but there was insufficient evidence for combined treatment versus oral anticoagulation alone. Limitations in the reporting and analysis of the results make it difficult to adequately assess the robustness of these conclusions. Authors' objectives To assess the efficacy and safety of oral anticoagulation, with and without aspirin, for the secondary prevention of myocardial infarction (MI). Searching MEDLINE (1966

DARE.2004

380. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis

The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis Gerson L B, Triadafilopoulos G, Gage B F Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Seven strategies for the management of anticoagulants in the periendoscopic period for patients with atrial fibrillation were investigated. The strategies were as follows. Continue warfarin: a colonoscopy was performed without interrupting warfarin therapy. Hold warfarin

NHS Economic Evaluation Database.2004